-
Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer
-
Chan Lee, Seung Jo Kim, Joong Yol Na, Chang Suk Park, Sun Young Lee, In Ho Kim, Yu Kyoung Oh
-
Cancer Res Treat. 2003;35(4):314-322. Published online August 31, 2003
-
DOI: https://doi.org/10.4143/crt.2003.35.4.314
-
-
 Abstract
 PDF
- PURPOSE
The biallelic expression of insulin-like growth factor-II (IGF2) and H19 has been reported to be associated with the progression of several tumors. Here, the promoter usage and expression levels of IGF2 and H19 are reported to be altered in cervical and endometrial cancers showing loss of imprinting (LOI).
MATERIALS AND METHODS
The imprinting status of IGF2 and H19 was examined in 32 cervical carcinomas, their matched normal tissues, 13 endometrial cancer and 33 normal endometrial tissues.
RESULTS
The LOI of IGF2 was observed in 7 of 18 (39%) and 1 of 13 (8.3%) informative cervical carcinomas and informative endometrial cancers, respectively. The LOI of the H19 gene was detected in 5 of 14 (36%) and in all 11 (100%) informative cervical carcinoma cases and informative endometrial cancer cases, respectively. The use of promoter P1 was observed in the LOI tumors of IGF2, but not in the tumors showing maintenance of IGF2 imprinting (MOI), or in cervical and endometrial cancers. Unlike MOI tumors, some LOI tumors revealed a lack of IGF2 transcription from the promoter P3. The LOI tumors of IGF2 showed increased expression of the IGF2 level, but a down-regulation of the H19, relative to normal tissues, whereas the MOI tumors revealed no significant alterations.
CONCLUSION
These results suggest that the promoter P1 could be involved in the biallelic expression of IGF2, and that the altered expression of the IGF2 and H19 levels might be associated with the progression of cervical and endometrial cancers that exhibit biallelic IGF2 expression.
-
Citations
Citations to this article as recorded by  - Long Noncoding RNA Mediated Regulation in Human Embryogenesis, Pluripotency, and Reproduction
Lei Liu, Fang Fang, Xinyi Lu
Stem Cells International.2022; 2022: 1. CrossRef - Adherence to Cancer Prevention Guidelines and Endometrial Cancer Risk: Evidence from a Systematic Review and Dose-Response Meta-analysis of Prospective Studies
Hui Sun, Qing Chang, Ya-Shu Liu, Yu-Ting Jiang, Ting-Ting Gong, Xiao-Xin Ma, Yu-Hong Zhao, Qi-Jun Wu
Cancer Research and Treatment.2021; 53(1): 223. CrossRef - The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers
Faiza Naz, Imran Tariq, Sajid Ali, Ahmed Somaida, Eduard Preis, Udo Bakowsky
Cancers.2021; 13(23): 6102. CrossRef - Deregulation of H19 is associated with cervical carcinoma
Anirban Roychowdhury, Sudip Samadder, Pijush Das, Dipanjana Indra Mazumder, Ankita Chatterjee, Sankar Addya, Ranajit Mondal, Anup Roy, Susanta Roychoudhury, Chinmay Kumar Panda
Genomics.2020; 112(1): 961. CrossRef - PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth
Neha Singh, Sathish K. R. Padi, Jeremiah J. Bearss, Ritu Pandey, Koichi Okumura, Himisha Beltran, Jin H. Song, Andrew S. Kraft, Virginie Olive
Molecular Oncology.2020; 14(5): 974. CrossRef - An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance
Behnam Alipoor, Seyedeh Nasrin Parvar, Zolfaghar Sabati, Hamid Ghaedi, Hassan Ghasemi
Molecular Biology Reports.2020; 47(8): 6357. CrossRef - Advances of Long Noncoding RNAs-mediated Regulation in Reproduction
Kang-Sheng Liu, Tai-Ping Li, Hua Ton, Xiao-Dong Mao, Ya-Jun Chen
Chinese Medical Journal.2018; 131(2): 226. CrossRef - Dysregulated expression of long noncoding RNAs in gynecologic cancers
Elahe Seyed Hosseini, Matthieu Meryet-Figuiere, Hamed Sabzalipoor, Hamed Haddad Kashani, Hossein Nikzad, Zatollah Asemi
Molecular Cancer.2017;[Epub] CrossRef
-
4,519
View
-
35
Download
-
8
Crossref
|
KCA
